Orexo presents sales potential of the pharmaceutical pipeline and digital therapies during the Capital Markets Day
Uppsala, Sweden – March 17, 2020. Orexo AB (publ.), today hosts a Capital Market Day in Stockholm, Sweden. On the day the company will present an overview of the company’s growth strategy, pharmaceutical pipeline and digital therapies. In the presentation of the pharmaceutical pipeline the company will present the market dynamics, the competitive landscape and the sales potential in the US of each of the three main pipeline projects: · OX124, a powerful rescue medication, designed to reverse opioid overdoses, including those from synthetic opioids like fentanyl. OX124 is estimated